VSM Wealth Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
4,218
-128
-3% -$29.8K 0.28% 37
2026
Q1
$1.06M Sell
4,346
-162
-4% -$37.7K 0.32% 37
2025
Q4
$933K Sell
4,508
-10
-0.2% -$1.98K 0.28% 38
2025
Q3
$838K Sell
4,518
-805
-15% -$138K 0.26% 38
2025
Q2
$813K Buy
5,323
+10
+0.2% +$1.54K 0.27% 42
2025
Q1
$881K Buy
5,313
+10
+0.2% +$1.56K 0.32% 38
2024
Q4
$767K Buy
+5,303
New +$822K 0.27% 41

Other funds holding JNJ

VSM Wealth Advisory's JNJ Position: Q2 2026 in Review

VSM Wealth Advisory reduced its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2026, selling an estimated $29.8K and leaving 4,218 shares worth $1.07M. The position accounts for 0.28% of the portfolio, ranked #37.

VSM Wealth Advisory first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • VSM Wealth Advisory held 4,218 shares of Johnson & Johnson worth $1.07M as of Q2 2026.
  • VSM Wealth Advisory sold 128 Johnson & Johnson shares in Q2 2026, an estimated $29.8K.
  • Johnson & Johnson made up 0.28% of VSM Wealth Advisory's portfolio in Q2 2026, its #37 holding.
  • VSM Wealth Advisory first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.